Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma

Hugo J. A. Adams, Thomas C. Kwee

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)129-131
JournalBritish Journal of Haematology
Issue number1
Publication statusPublished - 2018

Cite this